Copyright
©The Author(s) 2026.
World J Hepatol. Feb 27, 2026; 18(2): 113348
Published online Feb 27, 2026. doi: 10.4254/wjh.v18.i2.113348
Published online Feb 27, 2026. doi: 10.4254/wjh.v18.i2.113348
Table 1 Demographics and laboratory findings among patients in the development cohort, n (%)
| Characteristics | Total (n = 159) | Evident histological liver injury | P value | |
| No (n = 87) | Yes (n = 72) | |||
| Demographic variables | ||||
| Male | 115/159 (72.3) | 55/87 (63.2) | 60/72 (83.3) | 0.005 |
| Age, year | 46.28 (10.84) | 42.98 (10.08) | 50.26 (10.44) | < 0.001 |
| Laboratory findings | ||||
| PLT, × 109/L | 167.87 (71.18) | 199.38 (59.86) | 129.81 (65.17) | < 0.001 |
| ALT, U/L | 41.20 (59.35) | 27.69 (23.82) | 57.52 (81.59) | 0.001 |
| AST, U/L | 35.45 (36.51) | 24.56 (10.74) | 48.61 (50.06) | < 0.001 |
| TP, g/L | 75.48 (5.01) | 75.56 (4.81) | 75.38 (5.27) | 0.83 |
| ALB, g/L | 46.46 (4.49) | 47.85 (3.49) | 44.79 (5.00) | < 0.001 |
| TBIL, μmol/L | 16.91 (15.96) | 15.27 (18.97) | 18.90 (11.14) | 0.15 |
| DBIL, μmol/L | 6.19 (8.66) | 4.90 (8.96) | 7.76 (8.06) | 0.04 |
| HBV-DNA, × 105 IU/mL | 17.68 (135.71) | 31.04 (182.56) | 1.55 (11.71) | 0.17 |
| HBsAg, IU/mL | 1439.43 (6674.76) | 1938.84 (8631.85) | 835.98 (2867.01) | 0.30 |
| HBeAg, IU/mL | 93.11 (571.93) | 166.89 (767.11) | 3.95 (20.55) | 0.05 |
| HBcAb, IU/mL | 187.65 (313.01) | 222.54 (324.45) | 145.48 (295.34) | 0.12 |
Table 2 Univariable and multivariable logistic regression model for predicting development of evident histological liver injury in patients with chronic hepatitis B
| Factor | Univariable analysis | Multivariable analysis | ||||
| OR | 95%CI | P value | OR | 95%CI | P value | |
| Male | 0.34 | 0.16-0.73 | 0.006 | |||
| Age, year | 2.04 | 1.43-2.92 | < 0.001 | |||
| L59 | 0.07 | 0.03-0.15 | < 0.001 | 0.15 | 0.06-0.38 | < 0.001 |
| PLT, × 109/L | 2.24 | 1.37-3.66 | 0.001 | 2.71 | 1.09-6.75 | 0.03 |
| ALT, U/L | 1.79 | 1.02-3.18 | 0.048 | 7.20 | 1.35-28.8 | 0.02 |
| AST, U/L | 5.56 | 2.14-14.47 | < 0.001 | 8.40 | 1.10-63.8 | 0.04 |
| ALB, g/L | 5.69 | 1.23-26.33 | 0.026 | |||
| TBIL, μmol/L | 2.31 | 1.33-4.02 | 0.003 | |||
| DBIL, μmol/L | 3.54 | 1.79-6.99 | < 0.001 | |||
- Citation: Dai ZS, Cao X, Jiang YF, He B. Predictive tool for evident histological liver injury in chronic hepatitis B patients: Development and validation. World J Hepatol 2026; 18(2): 113348
- URL: https://www.wjgnet.com/1948-5182/full/v18/i2/113348.htm
- DOI: https://dx.doi.org/10.4254/wjh.v18.i2.113348
